2017
DOI: 10.1016/j.ymgme.2016.11.161
|View full text |Cite
|
Sign up to set email alerts
|

A transgenic silkworm overexpressing human lysosomal enzyme as a novel resource for producing recombinant glycobiologics and its application to development of enzyme replacement therapy for lysosomal diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Historically, B. mori gained prominence due to silk production, but now it is one of the most valued model organisms for life science branches. Just to mention a few recent achievements, B. mori has been used as a bioreactor, for recombinant proteins production [7][8][9][10], while its silk is used to produce extraordinary silk-based biomaterials that exhibit great importance for the medical field [11]. The silk proteome contains two major proteins, namely fibroin and sericin.…”
Section: Introductionmentioning
confidence: 99%
“…Historically, B. mori gained prominence due to silk production, but now it is one of the most valued model organisms for life science branches. Just to mention a few recent achievements, B. mori has been used as a bioreactor, for recombinant proteins production [7][8][9][10], while its silk is used to produce extraordinary silk-based biomaterials that exhibit great importance for the medical field [11]. The silk proteome contains two major proteins, namely fibroin and sericin.…”
Section: Introductionmentioning
confidence: 99%